<DOC>
	<DOCNO>NCT00004936</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure MRI CT scan may improve ability detect cervical cancer determine extent disease . PURPOSE : Diagnostic trial determine effectiveness MRI CT scan evaluate invasive cervical cancer treatment patient .</brief_summary>
	<brief_title>MRI CT Scans Evaluate Invasive Cervical Cancer Before Treating Patients</brief_title>
	<detailed_description>OBJECTIVES : - Compare diagnostic performance magnetic resonance imaging ( MRI ) , compute tomography ( CT ) , clinical FIGO staging patient invasive cervical cancer . - Compare accuracy MRI , CT , clinical FIGO stag evaluation morphologic tumor prognostic factor FIGO stage IB1 stage IB2 great patient . - Examine value image assessment tumor prognostic factor ( alone combination ) predictor recurrence within 2 year surgery patient . - Evaluate quality life 12-month period stag treatment potentially change stag accuracy . OUTLINE : This multicenter study . Patients undergo compute tomography scan iodinate contrast dye follow magnetic resonance image scan without contrast comprise gadopentetate dimeglumine vice versa . Within 6 week first protocol image study , patient undergo one follow surgery : - Laparoscopic , transabdominal , transvaginal hysterectomy - Extrafascial total abdominal hysterectomy - Trachelectomy Quality life assess 1 12 month . Patients follow every 3 month 1 year every 6 month 1 year . PROJECTED ACCRUAL : A total 465 patient accrue study within 18 month .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm invasive cervical cancer , include invasive squamous cell carcinoma , adenocarcinoma , adenosquamous carcinoma FIGO stage IB1 clinically visible gross lesion OR FIGO stage IB2 great Scheduled one follow surgery participate Gynecological Oncology Group center : Laparoscopic , transabdominal , transvaginal hysterectomy Extrafascial total abdominal hysterectomy Trachelectomy Not schedule loop electrosurgical excision procedure cone biopsy PATIENT CHARACTERISTICS : Age : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No cardiac pacemaker Pulmonary : No asthma Other : Not pregnant No contraindication compute tomography ( CT ) ( e.g. , history allergy CT contrast medium ) No contraindication magnetic resonance imaging ( e.g. , intracranial vascular clip ) No nonmalignant general medical psychiatric condition would preclude consent surgery PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy invasive cervical cancer Surgery : See Disease Characteristics No prior surgery invasive cervical cancer Other : No prior medical treatment invasive cervical cancer</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>stage III cervical cancer</keyword>
	<keyword>stage IB cervical cancer</keyword>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
	<keyword>stage IIA cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>cervical squamous cell carcinoma</keyword>
	<keyword>cervical adenocarcinoma</keyword>
	<keyword>cervical adenosquamous cell carcinoma</keyword>
</DOC>